![Randall Lanier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Randall Lanier served as the Chief Scientific Officer at Chimerix, Inc. from 2007 to 2023.
Prior to that, he obtained an undergraduate degree from New College of Florida and a doctorate degree from The University of Texas Health Science Center at Houston.
Eerdere bekende functies van Randall Lanier
| Bedrijven | Functie | Einde |
|---|---|---|
| CHIMERIX, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2023 |
Opleiding van Randall Lanier
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
43
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
New College of Florida
 New College of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Health Science Center at Houston
 The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
